MCCULLOCH KEVIN (See Remarks) reported 1 transaction at XERIS BIOPHARMA HOLDINGS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 8/21/2026ACC: 0001867096-26-000069
Officer· See Remarks
Since Mar 2026
-21.92K
Net shares
Net seller
$177.1K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
21.92K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−21.92K
Price / share
$8.08
Trade value
$177.10K
% of position
1.3%
8/1/2026
1.68M→1.65M
Total
Net shares
−21.92K
Net value
-$177.10K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/1/2026 | F · Tax Withholding | −21.92K | $8.08 | $177.10K | 1.3% | 1.68M | 1.65M |
| Total | −21.92K | -$177.10K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned25K
Total
25K indirect25K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 25K | Indirect |
| Total | 25K | 25K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported